HomeNWRN • SWX
add
Newron Pharmaceuticals SpA
Previous close
CHF 7.18
Day range
CHF 7.00 - CHF 7.25
Year range
CHF 5.20 - CHF 11.20
Market cap
142.14M CHF
Avg Volume
81.27K
P/E ratio
8.89
Dividend yield
-
Primary exchange
SWX
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 23.99M | 1,246.70% |
Operating expense | 7.06M | 29.77% |
Net income | 12.70M | 373.88% |
Net profit margin | 52.94 | 120.34% |
Earnings per share | — | — |
EBITDA | 16.93M | 564.71% |
Effective tax rate | 17.90% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 9.83M | -22.01% |
Total assets | 63.91M | 147.07% |
Total liabilities | 62.45M | 11.97% |
Total equity | 1.46M | — |
Shares outstanding | 19.96M | — |
Price to book | 102.57 | — |
Return on assets | 66.22% | — |
Return on capital | 81.50% | — |
Cash Flow
Net change in cash
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 12.70M | 373.88% |
Cash from operations | -4.39M | -93.65% |
Cash from investing | 574.50K | -64.72% |
Cash from financing | 3.34M | 7,124.21% |
Net change in cash | -482.00K | 29.89% |
Free cash flow | 9.99M | 451.87% |
About
CEO
Founded
1999
Website
Employees
22
